requires no major surgery ,
reduces recovery time
and reduces the risk of rejection or infection .
Furthermore, its cost is potentially lower than that of joint prostheses , which could make it accessible to a larger number of patients.
🌍 A hope for millions of people
Osteoarthritis affects more than 300 million people worldwide today. This innovation therefore represents a major hope for improving the quality of life of patients suffering from chronic pain and loss of mobility.
🔬 Future prospects
Clinical trials are underway in Germany and several other European countries. If the results are confirmed, this gel could be commercialized in the coming years , marking a spectacular advance in the field of regenerative medicine .
